Abstract
Rosmarinus officinalis L. (Lamiaceae), popularly known as rosemary, is used for food flavoring, and in folk medicine, as an antispasmodic, analgesic, anti-rheumatic, diuretic, and antiepileptic agent. Rosemary is an herb widely used in folk medicine, cosmetics, and phytotherapy and for flavoring of food products. Studies have focused on various biological activities of the secondary metabolites of this plant, such as rosmarinic acid, which have powerful antioxidant, hepato-protective, antimicrobial, anti-nociceptive, and anti-inflammatory properties.
Keywords: Anti-oxidant, cytokines, phytotherapy, Rosmarinus officinalis, rosmarinic acid, anti-inflammatory agent.
Reviews on Recent Clinical Trials
Title:Rosmarinic Acid as Potential Anti-Inflammatory Agent
Volume: 13 Issue: 4
Author(s): Carmela Colica, Laura Di Renzo, Vincenzo Aiello, Antonino De Lorenzo and Ludovico Abenavoli*
Affiliation:
- Department of Health Sciences, University "Magna Graecia" of Catanzaro, Campus "Salvatore Venuta", 88100 Germaneto, Catanzaro,Italy
Keywords: Anti-oxidant, cytokines, phytotherapy, Rosmarinus officinalis, rosmarinic acid, anti-inflammatory agent.
Abstract: Rosmarinus officinalis L. (Lamiaceae), popularly known as rosemary, is used for food flavoring, and in folk medicine, as an antispasmodic, analgesic, anti-rheumatic, diuretic, and antiepileptic agent. Rosemary is an herb widely used in folk medicine, cosmetics, and phytotherapy and for flavoring of food products. Studies have focused on various biological activities of the secondary metabolites of this plant, such as rosmarinic acid, which have powerful antioxidant, hepato-protective, antimicrobial, anti-nociceptive, and anti-inflammatory properties.
Export Options
About this article
Cite this article as:
Colica Carmela , Di Renzo Laura , Aiello Vincenzo , De Lorenzo Antonino and Abenavoli Ludovico *, Rosmarinic Acid as Potential Anti-Inflammatory Agent, Reviews on Recent Clinical Trials 2018; 13 (4) . https://dx.doi.org/10.2174/157488711304180911095818
DOI https://dx.doi.org/10.2174/157488711304180911095818 |
Print ISSN 1574-8871 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-1038 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
NF-κB Signaling Pathway Inhibitors as Anticancer Drug Candidates
Anti-Cancer Agents in Medicinal Chemistry Downregulation of miRNA-14669 Reverses Vincristine Resistance in Colorectal Cancer Cells through PI3K/AKT Signaling Pathway
Recent Patents on Anti-Cancer Drug Discovery Selective COX-2 Inhibitors and Dual Acting Anti-inflammatory Drugs: Critical Remarks
Current Medicinal Chemistry Substance Abuse, HIV-1 and Hepatitis
Current HIV Research Therapeutic Targeting of Toll-Like Receptors in Gastrointestinal Inflammation
Current Pharmaceutical Design Thymidine Phosphorylase and Fluoropyrimidines Efficacy: A Jekyl and Hyde Story
Current Medicinal Chemistry - Anti-Cancer Agents Plant Defensins and Defensin-Like Peptides - Biological Activities and Biotechnological Applications
Current Pharmaceutical Design An Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future Research
Current Drug Abuse Reviews Can Cytokines be used as an Activation Marker in Rheumatoid Arthritis?
Endocrine, Metabolic & Immune Disorders - Drug Targets Mesalazine Activates Adenosine Monophosphate-activated Protein Kinase: Implication in the Anti-inflammatory Activity of this Anti-colitic Drug
Current Molecular Pharmacology A Discussion of Natural Rubber Latex Allergy with Special Reference to Children: Clinical Considerations
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Analysis of the Molecular Determinants of the Response of Chronic Myelogenous Leukaemia to Tyrosine Kinase Inhibitors
Current Pharmacogenomics Exercise Addiction- Diagnosis, Bio-Psychological Mechanisms and Treatment Issues
Current Pharmaceutical Design Players in ADP-ribosylation: Readers and Erasers
Current Protein & Peptide Science The Immune System Regulation in Sepsis: From Innate to Adaptive
Current Protein & Peptide Science Oral Agents in Multiple Sclerosis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Meet Our Editorial Board Member
Endocrine, Metabolic & Immune Disorders - Drug Targets Nanocarriers as Tools in Delivering Active Compounds for Immune System Related Pathologies
Recent Patents on Nanotechnology Current and Future Prospective of a Versatile Moiety: Imidazole
Current Drug Targets Differential Conservation of Nucleotides and Conservation/Mutation Correlations Between Nucleotides, with Special Reference to CXC 1 and 4 and FP Receptors Involved in Immune Regulation
Endocrine, Metabolic & Immune Disorders - Drug Targets